Cargando…
Biomarkers in T cell therapy clinical trials
T cell therapy represents an emerging and promising modality for the treatment of both infectious disease and cancer. Data from recent clinical trials have highlighted the potential for this therapeutic modality to effect potent anti-tumor activity. Biomarkers, operationally defined as biological pa...
Autor principal: | Kalos, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170602/ https://www.ncbi.nlm.nih.gov/pubmed/21851646 http://dx.doi.org/10.1186/1479-5876-9-138 |
Ejemplares similares
-
High-content molecular profiling of T-cell therapy in oncology
por: Novosiadly, Ruslan, et al.
Publicado: (2016) -
An integrative paradigm to impart quality to correlative science
por: Kalos, Michael
Publicado: (2010) -
Chimeric antigen receptor-engineered T cells in CLL: the next chapter unfolds
por: Kalos, Michael
Publicado: (2016) -
Chimeric Antigen Receptor Therapy for B-cell Malignancies
por: Porter, David L, et al.
Publicado: (2011) -
Clinical trials for stem cell therapies
por: Trounson, Alan, et al.
Publicado: (2011)